324 related articles for article (PubMed ID: 32971233)
1. Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease.
Evans AK; Ardestani PM; Yi B; Park HH; Lam RK; Shamloo M
Neurobiol Dis; 2020 Dec; 146():105089. PubMed ID: 32971233
[TBL] [Abstract][Full Text] [Related]
2. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
[TBL] [Abstract][Full Text] [Related]
3. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
[TBL] [Abstract][Full Text] [Related]
4. Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice.
Evans AK; Park HH; Saw NL; Singhal K; Ogawa G; Leib RD; Shamloo M
Neurobiol Aging; 2021 Oct; 106():241-256. PubMed ID: 34320462
[TBL] [Abstract][Full Text] [Related]
5. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.
Cao S; Fisher DW; Rodriguez G; Yu T; Dong H
J Neuroinflammation; 2021 Jan; 18(1):10. PubMed ID: 33407625
[TBL] [Abstract][Full Text] [Related]
7. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
8. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors.
Le L; Feidler AM; Li H; Kara-Pabani K; Lamantia C; O'Banion MK; Majewska KA
bioRxiv; 2023 Dec; ():. PubMed ID: 38106167
[TBL] [Abstract][Full Text] [Related]
10. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.
Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Thiele A; Heneka MT
Neuroscience; 2011 Mar; 176():396-407. PubMed ID: 21129451
[TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
12. Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease.
Flores-Aguilar L; Hall H; Orciani C; Foret MK; Kovecses O; Ducatenzeiler A; Cuello AC
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12835. PubMed ID: 35822518
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional response of murine microglia in Alzheimer's disease and inflammation.
Shippy DC; Watters JJ; Ulland TK
BMC Genomics; 2022 Mar; 23(1):183. PubMed ID: 35247975
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors.
Gyoneva S; Traynelis SF
J Biol Chem; 2013 May; 288(21):15291-302. PubMed ID: 23548902
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
[TBL] [Abstract][Full Text] [Related]
17. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
Tweedie D; Ferguson RA; Fishman K; Frankola KA; Van Praag H; Holloway HW; Luo W; Li Y; Caracciolo L; Russo I; Barlati S; Ray B; Lahiri DK; Bosetti F; Greig NH; Rosi S
J Neuroinflammation; 2012 May; 9():106. PubMed ID: 22642825
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
